RAC2

Chr 22ARAD

Rac family small GTPase 2

Also known as: EN-7, Gx, HSPC022, IMD73A, IMD73B, IMD73C, p21-Rac2

This gene encodes a member of the Ras superfamily of small guanosine triphosphate (GTP)-metabolizing proteins. The encoded protein localizes to the plasma membrane, where it regulates diverse processes, such as secretion, phagocytosis, and cell polarization. Activity of this protein is also involved in the generation of reactive oxygen species. Mutations in this gene are associated with neutrophil immunodeficiency syndrome. There is a pseudogene for this gene on chromosome 6. [provided by RefSeq, Jul 2013]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismAR/ADLOEUF 0.283 OMIM phenotypes
Clinical SummaryRAC2
🧬
Gene-Disease Validity (ClinGen)
immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia · ARModerate

Moderate evidence — consider for supplementary testing

3 total gene-disease associations curated

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.97). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
7 unique Pathogenic / Likely Pathogenic· 77 VUS of 227 total submissions
📖
GeneReview available — RAC2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.28LOEUF
pLI 0.966
Z-score 3.01
OE 0.00 (0.000.28)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.59Z-score
OE missense 0.34 (0.270.44)
42 obs / 122.8 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.00 (0.000.28)
00.351.4
Missense OE?0.34 (0.270.44)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 0 / 10.5Missense obs/exp: 42 / 122.8Syn Z: -0.45

This gene — mechanism propensity

DN
0.5967th %ile
GOF
0.6248th %ile
LOF
0.63top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFLOEUF 0.28
GOF1 literature citation
DN1 literature citation

Literature Evidence

DNDominant negative mutation of the hematopoietic-specific Rho GTPase, Rac 2, is associated with a human phagocyte immunodeficiency.1
GOFAt the adjacent amino acid, there is variation reported in somatic mutation databases6 and a single report of a constitutional p.(Glu62Lys) change in RAC2 that resulted in a gain of function2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

227 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic4
VUS77
Likely Benign118
Benign11
Conflicting2
3
Pathogenic
4
Likely Pathogenic
77
VUS
118
Likely Benign
11
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
2
0
0
3
Likely Pathogenic
0
4
0
0
4
VUS
4
64
8
1
77
Likely Benign
0
1
52
65
118
Benign
0
0
7
4
11
Conflicting
2
Total5716770215

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

17 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap RAC2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

RAC2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →